Three commercially available kits for 1,25-dihydroxyvitamm D [1,25(OH)2D1 determination were compared with a liquid-chromatographicmethod. Serum samples were analyzed for 1,25(OH)2D from 70 healthy subjects (age 2.2-17.5 years; 35 males, 35 females), some (n = 5) given orally high vitamin D3 doses. In addition, 1,25(OH)2D was measured in 28 patients with untreated diseases associated with low (n = 16) or high (n = 12) serum concentrations of the hormone. The results showed that the commercial kits were sufficiently accurate with respect to the comparison method and suitable for routine clinical work. 
We compared the results obtained by three commercial kits with those obtained by a method used for several years in our laboratory: two-step solid-phase extraction and high-performance liquid chromatography (HPLC) purification of 1,25(OH)2D, followed by a competitive protein binding assay (5).
MaterIals and Methods

Materials
Crystalline l,25(OH)2D3 was a gift from Hoffmann 
Methods
Each kit assay was performed as indicated in its instruction booklet. All the kit methods were based on acetonitrile extraction followed by single 'phase-switching" elution on CI8OH cartridges to separate 1,25(OH)2D from other serum components (4). Competitive protein binding assays (CPBA) for 1,25(OH)2D were carried out with use of calf thymus receptor, disequilibrium procedure, and dextran-coated charcoal to separate the bound from the free fraction (4, 6).
As previously described (5), the comparison method involves two consecutive solid-phase steps on C18 and Silica SepPak cartridges after acetonitrile extraction, followed by HPLC to finally resolve 1,25(OH)2D from the other serum components. In CPBA, we introduced minor modifications: as in the kit methods, we used calf thymus receptor instead of chick intestinal receptor (5), the former yielding more precise and sensitive results (6, 7); moreover, tracer addition to test tubes was delayed to increase assay sensitivity during the incubation step (6).
Samples
Blood samples were obtained from 70 healthy subjects (Table 1) in the morning (0800-0900) after an overnight fast. All subjects had heightsbetween the 25th and 75th percentiles for their age according to Tanner and Whitehouse'sstandards (8) and weight appropriate for height. None of them was affected by vitamin D deficiency 2After the conclusion of the study, the ITS Production B. V. Co.
(Wjchen, The Netherlands)was incorporatedby the Nichols Institute, San Juan Capistrano, CA. 
Serum was obtained by centrifugation
(1500 x aliquoted (1.0-mL portions), and stored at -20 #{176}C within 1 h after drawing the blood. Samples were assayed in duplicate within 1-4 months from sampling, 0.5-1.0 mL of serum was used for each determination (4, 6). Informed consent was obtained from the parents of the healthy subjects and of the patients, and the study was approved by the Ethical Committee for Human Investigation of our department.
Statistical Analyses
Data are reported as mean ± SD except as otherwise indicated. Mean data were compared by using Student's t-test or ANOVA, when appropriate; multiple regression analysis was performed with personal computer software (Abstat;
Anderson Bell, CO); P <0.05 was consideredto be significant in all instances.
Results and Discussion
One of the most important advances in extraction and purification of 1,25(OH)2D has been the introduction of microparticulate cartridges (9). In our study, no significant differences were found in the recovery of tritiated 1,25(OH)2D after "phase switching' elution with respect to the HPLC method (Table 2) . Precision, reproducibility, and detection limits are shown in Table 2 In our study, all the methods sufficiently discriminate between the healthy subjects and the patients with abnormal 1,25(OH)2D concentrations, and no significant differences were present among the mean 1,25(OH)2D values measured with the four methods in the healthy subjects and in the two groups of patients ( Table 3 ). In addition, multiple regression analysis showed a highly significant correlation between the results obtained with the commercial kits and those obtained with the comparison method (Table 4) .
Oral vitamin D3 administration significantly increases serum concentrations of vitamin D and some of its metabolites other than 1,25(OH)2D (1, 2) that may interfere with determination of 1,25(OH)2D itself in CPBA (3, 5). The results after oral vitamin D3 load in our subjects are reported in Table 5 . We found that oral vitamin D3 administration did not affect 1,25(OH)2D
determination.
These data indicate that all four methods sufficiently remove vitamin D and its metabolites from sera, therefore, purification of 1,25(OH)2D for 
